E. coli and S. aureus resist silver nanoparticles via an identical mechanism, but through different pathways

. 2024 Nov 21 ; 7 (1) : 1552. [epub] 20241121

Jazyk angličtina Země Velká Británie, Anglie Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid39572718

Grantová podpora
IGA_ PrF_2024_020 Univerzita Palackého v Olomouci (Palacký University Olomouc)

Odkazy

PubMed 39572718
PubMed Central PMC11582817
DOI 10.1038/s42003-024-07266-3
PII: 10.1038/s42003-024-07266-3
Knihovny.cz E-zdroje

Nanostructured materials with antibacterial activity face the same threat as conventional antibiotics - bacterial resistance, which reduces their effectiveness. However, unlike antibiotics, research into the emergence and mechanisms of bacterial resistance to antibacterial nanomaterials is still in its early stages. Here we show how Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli bacteria develop resistance to silver nanoparticles, resulting in an increase in the minimum inhibitory concentration from 1.69 mg/L for S. aureus and 3.38 mg/L for E. coli to 54 mg/L with repeated exposure over 12 and 6 cultivation steps, respectively. The mechanism of resistance is the same for both types of bacteria and involves the aggregation of silver nanoparticles leading to the formation of black precipitates. However, the way in which Gram-positive and Gram-negative bacteria induce aggregation of silver nanoparticles is completely different. Chemical analysis of the surface of the silver precipitates shows that aggregation is triggered by flagellin production in E. coli and by bacterial biofilm formation in S. aureus. However, resistance in both types of bacteria can be overcome by using pomegranate rind extract, which inhibits both flagellin and biofilm production, or by stabilizing the silver nanoparticles by covalently binding them to a composite material containing graphene sheets, which protects the silver nanoparticles from aggregation induced by the bacterial biofilm produced by S. aureus. This research improves the understanding of bacterial resistance mechanisms to nanostructured materials, which differ from resistance mechanisms to conventional antibiotics, and provides potential strategies to combat bacterial resistance and develop more effective antimicrobial treatments.

Zobrazit více v PubMed

O´Neill, J.

Baptista, P. V. et al. Nano-strategies to fight multidrug resistant bacteria-“A Battle of the Titans. PubMed DOI PMC

Muzammil, S. et al. Nanoantibiotics: Future nanotechnologies to combat antibiotic resistance. PubMed DOI

Makabenta, J. M. V. et al. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. PubMed DOI PMC

Frei, A., Verderosa, A. D., Elliott, A. G., Zuegg, J. & Blaskovich, M. A. T. Metals to combat antimicrobial resistance. PubMed DOI PMC

Slavin, Y. N., Asnis, J., Häfeli, U. O. & Bach, H. Metal nanoparticles: Understanding the mechanisms behind antibacterial activity. PubMed DOI PMC

Smith, W. P. J., Wucher, B. R., Nadell, C. D. & Foster, K. R. Bacterial defences: mechanisms, evolution and antimicrobial resistance. PubMed DOI

Graves, J. L. Jr et al. Rapid evolution of silver nanoparticle resistance in PubMed DOI PMC

Salas-Orozco, M. et al. Mechanisms of resistance to silver nanoparticles in endodontic bacteria: a literature review.

Faghihzadeh, F., Anaya, N. M., Astudillo-Castro, C. & Oyanedel-Craver, V. Kinetic, metabolic and macromolecular response of bacteria to chronic nanoparticle exposure in continuous culture. DOI

Stabryla, L. M. et al. Role of bacterial motility in differential resistance mechanisms of silver nanoparticles and silver ions. PubMed DOI

Gunawan, C., Teoh, W. Y., Marquis, C. P. & Amal, R. Induced adaptation of Bacillus sp. to antimicrobial nanosilver. PubMed DOI

Khan, S., Mukherjee, A. & Chandrasekaran, N. Silver nanoparticles tolerant bacteria from sewage environment. PubMed DOI

Yang, Y. & Alvarez, P. J. J. Sublethal concentrations of silver nanoparticles stimulate biofilm development. DOI

Ellis, D. H., Maurer-Gardner, E. I., Sulentic, C. E. W. & Hussain, S. M. Silver nanoparticle antibacterial efficacy and resistance development in key bacterial species.

Panáček, A. et al. Bacterial resistance to silver nanoparticles and how to overcome it. PubMed DOI

Valentin, E. et al. Heritable nanosilver resistance in priority pathogen: a unique genetic adaptation and comparison with ionic silver and antibiotics. PubMed DOI

Elbehiry, A., Al-Dubaib, M., Marzouk, E. & Moussa, I. Antibacterial effects and resistance induction of silver and gold nanoparticles against PubMed PMC

Kędziora, A. et al. Consequences of long-term bacteria’s exposure to silver nanoformulations with different physicochemical properties. PubMed DOI PMC

Panáček, A. et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. PubMed DOI

Jacqueline, C. & Caillon, J. Impact of bacterial biofilm on the treatment of prosthetic joint infections. PubMed DOI

Usui, M., Yoshii, Y., Thiriet-Rupert, S., Ghigo, J. M. & Beloin, C. Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance. PubMed PMC

Harrison, J. J., Ceri, H. & Turner, R. J. Multimetal resistance and tolerance in microbial biofilms. PubMed DOI

Black, C. E. & Costerton, J. W. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. PubMed DOI

Hall, C. W. & Mah, T. F. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. PubMed DOI

Venkatesan, N., Perumal, G. & Doble, M. Bacterial resistance in biofilm-associated bacteria. PubMed DOI

Craft, K. M., Nguyen, J. M., Berg, L. J. & Townsend, S. D. Methicillin-resistant: PubMed DOI PMC

Dsouza, F. P., Dinesh, S. & Sharma, S. Understanding the intricacies of microbial biofilm formation and its endurance in chronic infections: a key to advancing biofilm-targeted therapeutic strategies. PubMed DOI

El et al. Impact of environmental conditions (pH, ionic strength, and electrolyte type) on the surface charge and aggregation of silver nanoparticles suspensions. PubMed DOI

Joshi, A. S., Singh, P. & Mijakovic, I. Interactions of gold and silver nanoparticles with bacterial biofilms: molecular interactions behind inhibition and resistance. PubMed DOI PMC

Mann, R. et al. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance. PubMed PMC

Christensen, G. D. et al. Adherence of coagulase-negative Staphylococci to plastic tissue culture plates: a quantitative model for the adherence of Staphylococci to medical devices. PubMed DOI PMC

Panáček, A. et al. Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae. PubMed DOI

Meléndez, P. A. & Capriles, V. A. Antibacterial properties of tropical plants from Puerto Rico. PubMed DOI

Braga, L. C. et al. Pomegranate extract inhibits Staphylococcus aureus growth and subsequent enterotoxin production. PubMed DOI

Braga, L. C. et al. Synergic interaction between pomegranate extract and antibiotics against PubMed DOI

Sorrenti, V. et al. Beneficial effects of pomegranate peel extract and probiotics on pre-adipocyte differentiation. PubMed PMC

Er-rahmani, S. et al. Plant-derived bioactive compounds for the inhibition of biofilm formation: a comprehensive review. PubMed

Salim, A. et al. Antimicrobial and antibiofilm activities of pomegranate peel phenolic compounds: varietal screening through a multivariate approach. DOI

Hassan, M. G. et al. Pomegranate extract-mediated synthesis of silver nanoparticles: a potential dual-anticancer and antimicrobial agent.

Nasiriboroumand, M., Montazer, M. & Barani, H. Preparation and characterization of biocompatible silver nanoparticles using pomegranate peel extract. PubMed DOI

Panáček, D. et al. Silver covalently bound to cyanographene overcomes bacterial resistance to silver nanoparticles and antibiotics. PubMed PMC

Hochvaldová, L. et al. Restoration of antibacterial activity of inactive antibiotics via combined treatment with a cyanographene/Ag nanohybrid. PubMed DOI PMC

Stepanovic, S. et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. PubMed

Asadishad, B., Hidalgo, G. & Tufenkji, N. Pomegranate materials inhibit flagellin gene expression and flagellar-propelled motility of uropathogenic PubMed DOI

Bakandritsos, A. et al. Cyanographene and graphene acid: emerging derivatives enabling high-yield and selective functionalization of graphene. PubMed DOI PMC

Hochvaldova, L. et al. Numerical source data for graphs [Data set].

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...